{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.085B vs. cons $1.080B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.72 vs. cons $0.71",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~5.1% vs. cons 5.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$3.00 vs. cons $2.99 (FY2026; predicted range $2.95-$3.05)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 core revenue growth midpoint",
      "prediction": "BETTER",
      "answer": "guide ~3.5% vs. cons 3.0% (FY2026; predicted range 3%-4%)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 adjusted EPS",
      "prediction": "LOWER",
      "answer": "guide ~$0.71 vs. cons $0.72 (Q3 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "Day-5 residual +0.5% vs. day-1 residual +1.5%: a modest FY2026 raise and stronger core-growth outlook support the initial move, but Q3 EPS below the ~$0.72 consensus and difficult Q4 selling-day comparisons limit out-period estimate revisions, causing part of the post-earnings gain to fade.",
  "day5_confidence": "LOW"
}